tradingkey.logo
tradingkey.logo
検索

Takeda Pharmaceutical Co Ltd

TAK
ウォッチリストに追加
15.720USD
-0.120-0.76%
終値 06/24, 16:00ET15分遅れの株価
50.21B時価総額
40.98直近12ヶ月PER

詳細情報 Takeda Pharmaceutical Co Ltd 企業名

Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research and development, manufacture, sale and licensing of pharmaceuticals. The Company focuses on the main business areas of gastrointestinal diseases, rare diseases, plasma derivatives (immune diseases), oncology (cancer), and neuroscience (neuropsychiatric diseases). The Company focuses on three research and development areas: innovative biopharmaceuticals with the focus on gastrointestinal and inflammatory diseases, neuroscience, and oncology, plus plasma derivatives and vaccines. Most of the pharmaceuticals treat rare diseases in the focus disease areas and the plasma derivatives area. The Company operates in Japan, the United States, Europe, and China.

Takeda Pharmaceutical Co Ltdの企業情報

企業コードTAK
会社名Takeda Pharmaceutical Co Ltd
上場日Jun 21, 2085
最高経営責任者「CEO」Weber (Christophe)
従業員数47455
証券種類Depository Receipt
決算期末Jun 21
本社所在地4F
都市CHUO-KU
証券取引所NASDAQ OMX NASDAQ Basic NYSE
Japan
郵便番号103-8668
電話番号81332782111
ウェブサイトhttps://www.takeda.com/
企業コードTAK
上場日Jun 21, 2085
最高経営責任者「CEO」Weber (Christophe)

Takeda Pharmaceutical Co Ltdの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. John M. Maraganore, Ph.D.
Dr. John M. Maraganore, Ph.D.
Independent Director
Independent Director
7.60K
--
Mr. Christophe Weber
Mr. Christophe Weber
President, Chief Executive Officer, Representative Director
President, Chief Executive Officer, Representative Director
--
--
Dr. Andrew S. Plump, Ph.D.
Dr. Andrew S. Plump, Ph.D.
President of Research & Development, Director
President of Research & Development, Director
--
--
Mr. Tokumasa Takeda
Mr. Tokumasa Takeda
Global Finance Chief Accounting Officer & Corporate Controller
Global Finance Chief Accounting Officer & Corporate Controller
--
--
Mr. Michel Orsinger
Mr. Michel Orsinger
Independent Director
Independent Director
--
--
Ms. Emiko Higashi
Ms. Emiko Higashi
Independent Director
Independent Director
--
--
Mr. Yoshiaki Fujimori
Mr. Yoshiaki Fujimori
Independent Director
Independent Director
--
--
Mr. Koji Hatsukawa
Mr. Koji Hatsukawa
Independent Director
Independent Director
--
--
Mr. Jean-Luc Butel
Mr. Jean-Luc Butel
Independent Director
Independent Director
--
--
Mr. Ian T. Clark
Mr. Ian T. Clark
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. John M. Maraganore, Ph.D.
Dr. John M. Maraganore, Ph.D.
Independent Director
Independent Director
7.60K
--
Mr. Christophe Weber
Mr. Christophe Weber
President, Chief Executive Officer, Representative Director
President, Chief Executive Officer, Representative Director
--
--
Dr. Andrew S. Plump, Ph.D.
Dr. Andrew S. Plump, Ph.D.
President of Research & Development, Director
President of Research & Development, Director
--
--
Mr. Tokumasa Takeda
Mr. Tokumasa Takeda
Global Finance Chief Accounting Officer & Corporate Controller
Global Finance Chief Accounting Officer & Corporate Controller
--
--
Mr. Michel Orsinger
Mr. Michel Orsinger
Independent Director
Independent Director
--
--
Ms. Emiko Higashi
Ms. Emiko Higashi
Independent Director
Independent Director
--
--

よくある質問

Takeda Pharmaceutical Co Ltdの上位5名の株主は誰ですか?

Takeda Pharmaceutical Co Ltdの上位5名の株主は以下のとおりです。Dr. John M. Maraganore, Ph.D.

Takeda Pharmaceutical Co Ltd(TAK)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Takeda Pharmaceutical Co Ltdの株式を保有している機関は637社あり、保有株式の総市場価値は約85.31Mで、全体の2.70%を占めています。2025Q4と比較して、機関の持ち株は-8142483.00増加しています。

Takeda Pharmaceutical Co Ltdの最大の収益源は何ですか?

2026Q1において、Gastrointestinal diseases部門がTakeda Pharmaceutical Co Ltdにとって最大の収益を生み出しており、その金額は385.81Bで、全収益の32.37%を占めています。
KeyAI